SSVEP Evaluation of Brain Function (PRO)
1 other identifier
observational
1,000
1 country
1
Brief Summary
The investigational device used in this clinical investigation, the Nurochek PRO System (NCPRO), is a portable electroencephalogram (EEG) headset which delivers a visual stimulus and measures a VEP. The visual stimulus is delivered to the subjects' eyes via light-emitting diodes, and the EEG measures the user's visual-evoked potential. This headset communicates with an application on a computer, which processes the signals and transmits them to a secure cloud server for analysis and storage of the data. Nurochek PRO is a development of the previously FDA cleared Nurochek System. The primary objective of this clinical investigation was to evaluate the performance of the investigational device (NCPRO) against clinical diagnosis of detection of mild traumatic brain injury (mTBI). The primary endpoint outlined for this study was set at the collection of 100 valid investigational device readings from individuals with concussion and 500 valid investigational device readings from healthy individuals who have had a plausible mechanism of sustaining a concussion, but do not have one. Additionally, readings from healthy individuals are also to be acquired. The aim of this study was to collect data from 100 readings from individuals with concussion. The initial assumption was that sites would provide players pre-season and make players available for testing post-concussion. In practice, some sites provided player data only post-concussion event (such as medical clinics). Participants were acquired from sporting clubs, medical clinicals and schools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 22, 2023
CompletedFirst Posted
Study publicly available on registry
August 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedMay 16, 2024
May 1, 2024
3 years
August 22, 2023
May 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Steady State Visual Evoked Potential
A measure of the steady state visual evoked potential (SSVEP) from the device and comparison with a Doctor's diagnosis.
5 days
Secondary Outcomes (1)
Recovery from m TBI
30 days
Study Arms (3)
Baseline
This cohort contains individuals tested at baseline, usually in the pre-season of their sporting season
Concussed
This cohort contains individuals who have had a concussion, diagnosed by a doctor.
Suspected Concussion
This cohort contains individuals suspected of having a concussion, but were cleared by a medical professional and do not have a concussion.
Interventions
Non-invasive, non-interventional SSVEP EEG device
Eligibility Criteria
As above.
You may qualify if:
- Individuals aged 12 years and older, participating in sport-related activities.
You may not qualify if:
- Individuals are excluded if they have a history of seizures, history of epilepsy, structural brain injuries, legal blindness, or sensitivity to flashing lights.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Headsafe MFGlead
Study Sites (1)
Headsafe
Sydney, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Craig Donaldson, MBBS
Principal Investigator
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2023
First Posted
August 28, 2023
Study Start
January 1, 2023
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share